NEUROPHET, Inc. (KOSDAQ:380550)

South Korea · Delayed Price · Currency is KRW

7,070.00

-740.00 (-9.48%)

Jul 28, 2026, 3:30 PM KST

NEUROPHET Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	2,562	2,615	2,216
Revenue Growth	-	18.00%	-
Gross Profit	2,568	2,611	2,215
Operating Income	-17,771	-16,549	-14,649
Net Income	-23,297	-22,389	-15,101
Earnings Per Share	-2108.77	-2301.74	-4091.00
EPS Growth	-	-	-

Revenue by Segment

Fiscal Year	FY TTM	FY NaN	FY NaN
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Neurophet SCALE PET	922.21	336.06	181.82
Neurophet AQUA	583.06	662.64	365.83
Imaging CRO Service	516.31	522.02	127.74
Other	194.63	41.49	22.07

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	18,739	23,768	6,017
Total Debt	524.4	5,530	4,812
Net Cash (Debt)	18,214	18,238	1,206
Net Cash Growth	-	1412.64%	-
Net Cash Per Share	1648.73	1875.00	326.63

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-15,708	-15,067	-12,613
Capital Expenditures	-571.39	-265.46	-248.74
Free Cash Flow	-16,279	-15,332	-12,862
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Gross Margin	100.21%	99.85%	99.94%
Operating Margin	-693.52%	-632.84%	-660.98%
Pretax Margin	-909.17%	-856.15%	-681.41%
Profit Margin	-909.17%	-856.15%	-681.41%
FCF Margin	-635.32%	-586.30%	-580.35%

Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
PS Ratio	33.66	99.01	-